Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of ending self-isolation rules for people with covid-19 on immune-suppressed transplant recipients' (a) mortality and (b) quality of life.

No specific assessment has been made. However, those who are at higher risk of serious outcomes from COVID-19 may be eligible for antiviral and other therapeutic treatments and a focused vaccination programme. On 1 April 2022, updated guidance for those with immunosuppression was issued and we continue to engage with the relevant patient and stakeholder groups.